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The First Fluorescent Diboronic Acid Sensor
Specific for Hepatocellular Carcinoma Cells
Expressing Sialyl Lewis X#
lated acute phase reactants in HCC [10–14], and some
inflammatory molecules appear to be involved in the
progression of HCC. Alpha-fetoprotein, for example, is
heavily fucosylated in chronic hepatitis and HCC [15].
Normally differentiated hepatocytes do not express
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Georgia State University sLex, but chronically diseased liver expresses high lev-
els of sLex, and this is associated with a high degree33 Gilmer St. S.E.
Atlanta, Georgia 30303 of carcinogenicity [16].
Diagnosis and staging of HCC is often limited due to2 Department of Pediatrics
University of North Carolina inability to detect advanced disease. Treatment of HCC
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by drug resistance [17]. Biosensors that could both rec-
ognize occult metastasis and provide targeted delivery
of treatment could potentially improve chances for suc-Summary
cess in this disease. Herein, we describe our search for
fluorescent diboronic acid compounds that can specifi-Carbohydrate antigens with subterminal fucosylation
have been implicated in the development and progres- cally recognize sLex [18]. One compound was able to
fluorescently label HCC lines that express the targetsion of several cancers, including hepatocellular carci-
noma (HCC). Fluorescent sensors targeting fucosy- carbohydrate. This represents the first example of a
small organic molecule being used to fluorescently labellated carbohydrate antigens could potentially be used
for diagnostic and other applications. We have de- cells based on the specific recognition of cell-surface
carbohydrate structures.signed and synthesized a series of 26 diboronic acid
compounds as potential fluorescent sensors for such
carbohydrates. Among these compounds, 7q was able
Results and Discussionto fluorescently label cells expressing high levels of
sLex (HEPG2) within a concentration range of 0.5 to
Chemistry10M. This compound (7q) did not label cells express-
For this project, we selected sLex (Figure 1) as our initialing Lewis Y (HEP3B), nor cells without fucosylated
target for sensor design because it is implicated in theantigens (COS7). This represents the first example of
development of liver and colon cancer [16, 19]. Criticala fluorescent compound labeling cells based on cell
to the development of high affinity and high specificitysurface carbohydrate structures.
sensors for carbohydrates is the need for recognition
moieties that have strong interactions with the functionalIntroduction
groups, such as hydroxyl groups, on a carbohydrate. It
has been known since the 1940s that boronic acids canFluorescent sensors capable of recognizing specific
bind compounds with a diol structural motif with highcell-surface biomarkers are useful diagnostics. Our lab-
affinity [20]. By taking advantage of this strong interac-oratory has been particularly interested in the develop-
tion, several molecular recognition systems for carbo-ment of fluorescent sensors for carbohydrates. It is
hydrates based on boronic acid moieties have beenknown that cell-surface carbohydrates, as part of glyco-
developed [21–31]. Recently, our lab has undertakensylated proteins and lipids, often form characteristic
extensive studies of the interaction of boronic acid andsignatures of different cell types [1, 2]. In particular,
diols and achieved a much greater understanding of thecertain cell surface carbohydrates, such as sialyl Lewis
factors that influence this complexation process [32].X (sLex), sialyl Lewis a (sLea), Lewis X (Lex), and Lewis
Our group has also developed a new method of makingY (Ley) (Figure 1), have been associated with the devel-
fluorescent sensors for sugars through template-directedopment and progression of many types of cancers [3–6],
polymerization of boronic acid monomers [33, 34]. How-including hepatocellular carcinoma (HCC), one of the
ever, most of these early efforts were focused on mono-most common carcinomas worldwide [7].
saccharides. Effort in designing sensors for cell-surfaceOne specific example associated with the develop-
polysaccharides has been very limited [35]. Possiblement and progression of human carcinomas is their abil-
reasons for this include the complexity of polysaccha-ity to express (1,3)-fucosylated carbohydrates, which
rides and their conformational flexibility, which makesare important components of ligands involved in selec-
sensor construction difficult.tin-mediated cell adhesion and inflammatory responses
In designing sensors for saccharides, it is essential[8, 9]. Inflammatory cytokines can increase the meta-
that binding also trigger a reporting event. It has beenbolic activity and expression of several heavily glycosy-
known that anthracene fluorescence can be quenched
by nitrogen lone pair electrons on an amino group (Fig-
*Correspondence: bwwmd@med.unc.edu (Weston); wang@gsu.edu
ure 2). However, this quenching can be removed or re-(Wang)
duced if lone pair electrons are masked through B-N# A major part of this work was performed at North Carolina State
University, Department of Chemistry. bond formation [23, 36]. Since binding with a carbohy-
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Figure 1. Structures of Lewis Oligosaccharides
drate is known to increase the acidity of boronic acid, tial sensors (7, Figure 3). In doing so, we sampled a
series of dicarboxylic acid linkers with different length,the boronic ester formation will also increase the B-N
bond strength, which results in the masking of the nitro- rigidity, and spatial orientation in search of an optimal
arrangement.gen lone pair electrons. Consequently, the fluorescence
intensity of the anthracene system increases (Figure 2). The synthesis of these compounds is shown in Figure
3. Starting from the readily available hydroxyaldehydeSeveral laboratories, including ours, have used this sys-
tem developed by the Shinkai group in the synthesis 1 [38], upon reductive amination with methylamine in
MeOH/THF and NaBH4, amine 2 was obtained in 90%of boronic acid-based fluorescent sensors, for mostly
monosaccharides [23–25, 37]. In this project, we also yield. The Boc-protected compound 3 was obtained in
78% yield by treatment of 2 with di-tert-butyldicarbo-chose to use the Shinkai system as the reporter moiety
for the synthesis of diboronic compounds as potential nate [(Boc)2O] in MeOH in the presence of triethylamine
(TEA). This was followed by oxidation with pyridine sulfursensors for sLex.
For the construction of fluorescent sensors for sLex, trioxide in dimethylsulfoxide (DMSO) in the presence of
TEA to give aldehyde 4 in quantitative yield. The resultingwe envisioned that diboronic acid compounds with the
proper spatial arrangement of the two boronic acid moi- aldehyde 4 was then converted to amine compound 5
in 83% yield through reductive amination. Amine 5 waseties, which are complementary to the multiple pairs of
diols, have the potential for highly specific recognition coupled with various diacids using 1-(2-dimethylamino-
of the target carbohydrate. Such a concept has been propyl)-3-ethylcarbodiimide hydrochloride (EDC) as the
demonstrated several times in the preparation of diboro- activating reagent to furnish compounds 6 in 30–90%
nic acid sensors for glucose and other monosaccharides yields. After deprotection of compounds 6 with trifluoro-
[23–25, 37]. In this project, we chose to use a spacer acetic acid (TFA), the unprotected free amines were
to link, through amide bond formation, two fluorescent then reacted with boronate 8 [23] in the presence of
boronic acid compounds for the synthesis of the poten- potassium carbonate to give the diboronic acids 7 (Table
1) in 30%–80% yields.
These compounds are designed to show significant
fluorescence intensity changes upon binding with a
complementary carbohydrate. In screening for their
binding with the target carbohydrate, sLex, the fluores-
cence intensity changes of the sensor solutions upon
addition of the carbohydrate were determined. Such
experiments were conducted in a mixture of methanol
and 0.1 M phosphate buffer (pH 7.4) (1:1, v/v). Methanol
was used to improve the solubility of the sensor com-
pounds. The sensor (7) concentration was fixed at 1 
105 or 1  106 M, and the concentration of sLex was
set at 60 M. The fluorescence intensity change profileFigure 2. Illustration of the Anthracene-Based Photoinduced Elec-
tron Transfer System for these diboronic acids is shown in Figure 4. It can be
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Table 1. Chemical Structures of Diboronic Acids 7a-z
Compounds R Compounds R
7a -(CH2)10- 7n
7b 7o
7c 7p -(CH2)5-
7d 7q
7e -(CH2)3- 7r
7f 7s
7g 7t
7h -(CH2)2- 7u
7i -(CH2)6- 7v
7j -(CH2)20- 74
Figure 3. Dibronic Acid Synthesis 7k 7x -(CH2)14-
(a) i. MeOH, THF, MeNH2 (40%, wt), ii. NaBH4, 90%; (b) MeOH, TEA,
(Boc)2O, 78%; (c) DMSO, TEA, Py•SO3, 100%; (d) i. MeOH, THF,
MeNH2 (40%, wt), ii. NaBH4, 83%. (e) CH2Cl2, EDC, HOOCRCOOH, 7l 7y -(CH2)4-
30–90%; (f) i. TFA, CH2Cl2, ii. CH3CN, 8, K2CO3, 30–80%.
7m -(CH2)12- 7z
seen that these compounds showed varying degrees of
fluorescence intensity changes upon addition of sLex,
indicating varying degrees of affinity for the carbohy-
drate. Among them, compound 7q showed the greatest has been well described [16, 39]. These observations
fluorescence intensity change upon mixing with sLex. have been linked to the development of cirrhosis, a
frequent precursor of HCC. Such findings are compara-
ble to chronic inflammatory states preceding develop-Biology
Again, our rationale for sensor design targets carbohy- ment of colon carcinoma [8]. The specific role(s), if any,
for sLex in transformation and progression to HCC are,drate antigens associated with the development of can-
cer. Overexpression of sLex in chronic inflammatory dis- however, not well understood. Biosensors that could
sensitively trace this development in vivo would likelyeases of the liver has been reported in several contexts
by multiple investigators [15, 16, 39, 40]. Current evi- further our understanding of hepatocarcinogenesis, in
addition to providing new diagnostic and therapeuticdence in our laboratory suggests that sLex serves as a
marker for hepatocyte damage and regeneration, and approaches.
After demonstration of binding of the sensors to sLexits expression is likely controlled by hepatic cytokines
operating in autocrine loops [10–14]. Similarly, Lewis Y in solution, it was desirable to see whether 7q, the com-
pound that showed the most significant fluorescenceappears to be a sensitive marker for damaged intrahe-
patic bile ducts [40, 41], but its role in the inflammatory intensity increase upon addition of sLex, could bind the
biomarker sLex on cell surfaces [19, 42]. We thereforeprocess is much less evident. Loss and gain of sLex
expression in variously differentiated HCC specimens chose a cell line that selectively expresses sLex on the
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Figure 4. The Fluorescence Intensity Changes of the Diboronic Acids 7a-z upon Binding with sLex
Sensor concentrations: 1  105 or 1  106 M. sLex concentration: 6  105 M; ex  370 nm, em  426 nm.
surface, HEPG2 (Figure 5). To examine the selectivity of characterize surface glycan expression. Using two dif-
ferent monoclonal antibodies directed at sLex, HEPG2the sensor for cell surface sLex, HEP3B and COS7 cells
cells were found to express high levels, while HEP3Bwere labeled in parallel. COS7 expresses none of the
cells expressed little or none (Figure 5). Anti-Lewis Yfucosylated antigens associated with carcinoma pro-
monoclonal antibodies revealed the converse: high ex-gression and HEP3B expresses only the Lewis Y antigen
pression on HEP3B and little or no staining of HEPG2.[43, 44]. Flow cytometry analysis of HCC lines with anti-
None of the cell lines expressed Lewis X or sialyl Lewiscarbohydrate monoclonal antibodies was performed to
a, related antigens expressed on other forms of carci-
noma [9, 19, 42]. These cell lines were then used for the
fluorescent labeling studies with the sensors.
HEPG2 and control cell lines were incubated with
compound 7q and three other diboronic acids (7b, 7d,
7y) selected as controls, examined under fluorescent
microscopy, and photographed. Images were subjected
to densitometry measurement as described in Experi-
mental Procedures. As seen with sLex solution binding
studies summarized in Figure 4, Compound 7q was high-
est in mean gray value when binding HEPG2 cells ex-
pressing sLex (Figure 6). Compound 7q did not recog-
nize Lewis Y on HEP3B cells. Compound 7b avidly
bound Lewis Y-expressing HEP3B cells, which corre-
lates with solution binding studies using 7b and Lewis
Y (data not shown). Compound 7b did not recognize
sLex on HEPG2 cells at this concentration (1 M), again
correlating with solution binding studies (Figure 4). Even
at this relatively low concentration, compound 7y recog-
nized surface sLex and Lewis Y with equal avidity, con-
cordant with solution binding studies (data not shown).
Compound 7d, which had low affinity for both sLex and
Lewis Y in solution, did not label HEPG2 or HEP3B. None
of the compounds bound to COS7 cells at any of theFigure 5. Flow Cytometry Analysis of Surface Antigens on HEPG2,
HEP3B, and COS7 Cells concentrations tested. The above results showed that
the cell labeling matched well with the solution bindingCells were harvested, stained with monoclonal antibodies, and sub-
jected to flow cytometric analysis as described in experimental pro- studies using fluorimetry.
cedures. Anti-CD18 results are presented as negative controls. Images from a representative cell-labeling experiment
Monoclonal antibodies CSLEX-1 and KM93 both recognize sLex. are shown in Figure 7. HCC and control cell lines were
Data presented here are the representative mean fluorescence in-
incubated with compound 7q, examined under phasetensity values from four experiments. The antigen-positive popula-
contrast and fluorescent microscopy, and digitally pho-tion of HEPG2 and HEP3B cells was gated at 1.5  101 units, and
tographed as described in Experimental Procedures.over 95% of stained cells were identified by these procedures with
each primary antibody used. As expected, compound 7q labeled only HEPG2 cells,
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ments), indicating that sialic acid is required for binding
of 7q. To examine the role of the fucose moiety in 7q
binding, HEPG2 were also incubated with fucosidase
recognizing  (1,3)- and (1,4) –linked fucose (MDL num-
ber MFCD00130491, SIGMA #F3023). This specific fu-
cosidase reduced 7q binding by 50%–75% (mean gray
value 23.5  11, n  8 experiments). Fucosidases re-
cognizing other linkages (e.g.;  1,6, MDL number
MFCD01092200, SIGMA #F6272;  1,2, MDL number
MFCD01092199, SIGMA #F9272) had no significant ef-
fect on 7q binding (data not shown). Incubation with both
 (1,3/1,4)fucosidase and  (2,3)neuraminidase (same
buffers and conditions except pH 5.5) showed almost
complete inhibition of 7q binding (mean gray value less
than 10 2 for N7271/F3023-treated cells, n 4 experi-
ments). Taken together, these results indicate that 7q
likely requires both fucose and sialic acid residues whenFigure 6. Densitometry Quantification of Fluorescent Compounds
binding to sLex on cell surfaces.Binding to HCC and Control Cell Line
It is fortuitous that among this first group of diboronicCells were labeled with 1 M of sensors 7b, 7d, 7y, and 7q as
compounds, 7q was able to label sLex-expressing cellsdescribed in Experimental Procedures. One well was incubated only
at low concentrations (0.5 M) without cross-reactivityin methanol/PBS without compound as a negative control (“neg”).
Mean gray values (y axis) were determined after subtraction of cell- to Ley-expressing cells (HEP3B). This will serve as an
free background. Results from five experiments are summarized. excellent lead compound for further structural optimiza-
tions. However, much more work is needed to truly un-
derstand the structural features of 7q that led to thisexhibiting dose-responsive fluorescence over the range
specific labeling activity. Such work will involve exten-of 0.5–10M. Even at higher concentrations, (e.g., 5 M,
sive computational and conformational work and is be-Figure 7), 7q did not recognize Lewis Y on HEP3B cells.
yond the scope of this report.We also examined the selectivity of sensor 7b. Com-
pound 7b bound Lewis Y-expressing HEP3B cells at all
concentrations tested (0.5–10 M). At higher concentra- Significance
tions, 7b also labeled HEPG2 cells, suggesting cross-
reactivity with sLex (e.g., 5 M, Figure 7). Thus, sensor Our laboratory has a long-standing interest in the de-
velopment of small molecule sensors for various ana-7q alone appears to have both high sensitivity and speci-
ficity for sLex when compared to related compounds lytes. Such sensors can be used for diagnostic pur-
poses. They can also be considered antibody mimicsand carbohydrate antigens.
To examine whether all components of sLex were for the high-specificity recognition of cell biomarkers.
Antibodies have been used for the development ofessential for binding, HEPG2 cells (sLex-expressing)
were treated with neuraminidases specific for  (2,3) in vitro diagnostic and detection tools, targeted drug
delivery vectors, and tissue-specific imaging agents.sialic acid linkages (MDL number MFCD01092203,
SIGMA #N7271) and  (2,3)/ (2,6) sialic acid residues However, success in the in vivo application of anti-
body-based diagnostic and therapeutic agents has(MDL number MFCD01092201, SIGMA #N5521). Both
neuraminidases consistently reduced binding of 7q by been limited partly because of their poor stability, im-
munogenecity, poor permeability, and complexity in50%–75% (e.g.; mean gray value of control 69.8  4;
mean gray value of N7271-treated 25  9, n  8 experi- chemical conjugation with the diagnostic or imaging
Figure 7. Representative Fluorescent Label-
ing Studies of HEPG2, HEP3B, and COS7
Cells
HEPG2 cells express only sLex, HEP3B cells
express only Lewis Y, and COS7 cells do not
express either antigen. Compounds 7q (S-23)
and 7b (S-3) are used at 5M in the examples
shown. Excitation wavelength  370 nm and
emission wavelength  426 nm. Scale in
lower right corner indicates 10 m length.
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(10-Formyl-anthracen-9-ylmethyl)-methyl-carbamic acidagents. Small organic molecule-based compounds
tert-butyl ester (4)capable of specific recognition of cell-surface bio-
Compound 3 (2.30 g, 6.55 mmol) was dissolved in the mixture ofmarkers can be considered antibody mimics and can dry DMSO (20 mL) and trimethylamine (20 mL). To the solution thus
be used for the same type of applications. However, prepared was added the solution of pyridine sulfur trioxide (7.30 g,
the small organic molecule antibody mimics have the 45.9 mmol) dissolved in dry DMSO (20 mL) over a period of 30 min.
The reaction mixture was stirred at room temperature under nitrogenadvantage of having more desirable pharmaceutical,
for 30 min, and then poured into ice-water (300 mL), extracted withbiopharmaceutical, and chemical properties for the
ethyl acetate (3  100 mL), dried over MgSO4. Solvent evaporationdevelopment of pharmaceutical agents. The fluores-
gave a yellow solid (2.30 g, 100%) without further purification. 1H
cent sensor described in this paper represents the NMR (CDCl3)  11.51 (s, 1H), 8.90 (d, J  8.5 Hz, 2H), 8.51 (d, J 
first example of a small organic molecule used to fluo- 8.5 Hz, 2H), 7.70–7.61 (m, 4H), 5.56 (s, 2H), 2.48 (s, 3H), 1.56 (s, 9H).
Methyl-(10-methylaminomethyl-anthracen-9-ylmethyl)-rescently label cells based on the cell-surface carbo-
carbamic acid tert-butyl ester (5)hydrate structures. Further development along this
Compound 4 (2.29 g, 6.56 mmol) was dissolved in the mixture ofline could lead to a number of small molecule antibody
THF (50 mL) and MeOH (50 mL). To this solution was added the
mimics that can be used for labeling, drug delivery, aqueous solution of methylamine (40%, wt, 20 mL), the reaction
and selective imaging applications. mixture was stirred at room temperature under nitrogen for 12 hr.
Sodium borohydride (1.00 g, 26.3 mmol) was added, and stirred for
30 min. After removal of the solvent in vacuo, the resulting residue
Experimental Procedures was dissolved in ethyl acetate (100 mL), washed with water (3 
50 mL), and dried over MgSO4. Solvent evaporation gave a crude
product, which was purified on a silica gel column, eluting withChemistry
MeOH/CH2Cl2 (1/2), giving compound 5 as a yellow solid (2.00 g,General
83%). 1H NMR (CDCl3)  8.44–8.39 (m, 4H), 7.56–7.53 (m, 4H), 5.51All 1H and 13C NMR spectra were recorded at 300 MHz and 75 MHz,
(s, 2H), 4.71 (s, 2H), 2.69 (s, 3H), 2.46 (s, 3H), 1.55 (s, 9H). 13C NMRrespectively, with tetramethylsilane as the internal standard. Column
(CDCl3)  155.6, 132.5, 131.0, 130.0, 125.8, 125.7, 125.4, 125.3, 124.9,chromatography was performed using silica gel (200-400 mesh) from
79.7, 47.8, 42.6, 36.9, 31.6, 28.6. IR (cm1): 1686. HRMS (FAB) calcu-Aldrich and neutral activated Brockmann I aluminum oxide (150
lated for C23H28N2O2 (M	) 364.2151, found 364.2159. Elemental analy-mesh) from EM Science. Elemental analyses were performed by
sis calculated for C23H28N2O2: C, 75.79; H, 7.74; N, 7.69. Found: C,Atlantic Microlab, Inc., Norcross, GA. Mass spectral analyses were
75.64; H, 7.71; N, 7.53.performed by the North Carolina State University Mass Spectro-
General Procedures for Preparation of Boc-Protectedmetry Facility and the University of Kansas Mass Spectrometry
Diamines (6)Laboratory. IR spectra were recorded on a Perkin-Elmer 1600 series
The di-acid (0.138 mmol, 0.5 equivalent) was dissolved in dry CH2Cl2spectrometer. Tetrahydrofuran (THF) was distilled from Na and
(20 mL), then 1-(2-dimethylaminopropyl)-3-ethylcarbodiimide hy-benzophenone. Acetonitrile (CH3CN) and dichloromethane (CH2Cl2) drochloride (EDC, 210 mg, 1.10 mmol, 4.0 equivalent) was added.were distilled from CaH2. All pH values were determined with an To this solution was added compound 5 (100 mg, 0.275 mmol, 1.0
Accumet 1003 Handhold pH/mV/Ion Meter (Fisher Scientific). A Shi-
equivalent). The reaction mixture was stirred at room temperature
madzu RF-5301 PC fluorimeter was used for the fluorescence stud-
under nitrogen for 12 hr, then washed with water (2  30 mL) and
ies. The excitation wavelength was set at 370 nm. dried over MgSO4. After solvent evaporation, the crude product was(10-Methylaminomethyl-anthracen-9-yl)-methanol (2) purified on a silica gel column, eluting with MeOH/CH2Cl2 to give
To the solution of compound 1 (2.00 g, 8.47 mmol) in MeOH (100 the product.
mL) and THF (50 mL) was added the aqueous solution of methyl- [10-({[11-({10-[(Tert-Butoxycarbonyl-methyl-amino)-
amine (40%, wt, 20 mL). The resulting mixture was stirred at room methyl]-anthracen-9-ylmethyl}-methyl-carbamoyl)-
temperature under nitrogen for 16 hr and then sodium borohydride undecanoyl]-methyl-amino}-methyl)-anthracen-9-
(0.90 g, 23.7 mmol) was added and the mixture stirred for another ylmethyl]-methyl-carbamic acid tert-butyl ester (6a)
30 min. After solvent evaporation, the resulting solid was dissolved Yield 52%. 1H NMR (CDCl3)  8.49–8.46 (m, 4H), 8.40–8.37 (m, 4H),
in the mixture of ethyl acetate (100 mL) and water (50 mL). The 7.59–7.54 (m, 8H), 5.71 (s, 4H), 5.54 (s, 4H), 2.60 (s, 6H), 2.49 (s, 6H),
organic phase was separated and dried over MgSO4. Solvent evapo- 2.40–2.35 (m, 4H), 1.72–1.55 (m, 22H), 1.36–1.31 (m, 12H). IR (cm1):
ration gave a crude product, which was purified on a silica gel 1684, 1637. HRMS (FAB) calculated for C58H75N4O6 (M	 	 H)
column, eluting with MeOH/CH2Cl2 (1/50), to give compound 2 as a 923.5687, found 923.5716.
yellow solid (1.91 g, 90%). 1H NMR (CDCl3)  8.45–8.42 (m, 2H), (10-{[(2-{2-[({10-[(Tert-Butoxycarbonyl-methyl-amino)-
methyl]-anthracen-9-ylmethyl}-methyl-carbamoyl)-8.37–8.34 (m, 2H), 7.55–7.52 (m, 4H), 5.64 (s, 2H), 4.65 (s, 2H), 2.65
methyl]-phenyl-acetyl)-methyl-amino]-methyl}-anthracen-(s, 3H). 13C NMR (CDCl3)  133.4, 131.7, 130.4, 130.3, 126.2, 126.1,
9-ylmethyl)-methyl-carbamic acid tert-butyl ester (6b)125.1, 124.8, 57.7, 48.2, 37.3. HRMS (FAB) calculated for C17H18NO
Yield 88%. 1H NMR (CDCl3)  8.47–8.39 (m, 8H), 7.53–7.49 (m, 8H),(M	 	 H) 252.1388, found 252.1373. Elemental analysis calculated for
7.26 (d, J  4.2 Hz, 4H), 5.74 (s, 4H), 5.53 (s, 4H), 3.81 (s, 4H), 2.62C17H17NO: C, 81.24; H, 6.82; N, 5.57. Found: C, 80.96; H, 6.86; N, 5.53.
(s, 6H), 2.45 (s, 6H), 1.56 (s, 18H). IR (cm1): 1684, 1643. HRMS (FAB)(10-Hydroxymethyl-anthracen-9-ylmethyl)-methyl-carbamic
calculated for C56H63N4O6 (M	 	 H) 887.4748, found 887.4733.acid tert-butyl ester (3)
10-{[(2-{2-[({10-[(Tert-Butoxycarbonyl-methyl-amino)-Compound 2 (2.10 g, 8.37 mmol), di-tert-butyl dicarbonate (3.80 g,
methyl]-anthracen-9-ylmethyl}-methyl-carbamoyl)-17.4 mmol), and trimethylamine (20 mL) were mixed in MeOH (120
methoxy]-phenoxy}-acetyl)-methyl-amino]-methyl}-mL) and then stirred at room temperature for 30 min. After removal
anthracen-9-ylmethyl)-methyl-carbamic acidof the solvent, the resulting residue was dissolved in ethyl acetate
tert-butyl ester (6c)
(100 mL), washed with water (3  50 mL), 10% aqueous solution of
Yield 44%. 1H NMR (CDCl3)  8.47 (d, J  9.0 Hz, 4H), 8.33 (d, J sodium carbonate (30 mL), and saturated brine (50 mL) and dried 9.0 Hz, 4H), 7.54–7.49 (m, 8H), 7.0 (s, 4H), 5.69 (s, 4H), 5.51 (s, 4H),
over MgSO4. Solvent evaporation gave a crude product, which was 4.79 (s, 4H), 2.60 (s, 6H), 2.47 (s, 6H), 1.60 (s, 18H). IR (cm1): 1672.
purified on a silica gel column, eluting with ethyl acetate/hexanes HRMS (FAB) calculated for C56H63N4O8 (M	 	 H) 919.4646, found
(1/50–1/2), giving compound 3 as a yellow solid (2.30 g, 78%). 1H 919.4681.
NMR (CDCl3)  8.51–8.43 (m, 4H), 7.60–7.55 (m, 4H), 5.71 (d, J  5.6 (10-{[(3-{4-[2-({10-[(Tert-Butoxycarbonyl-methyl-amino)-
Hz, 2H), 5.50 (s, 2H), 2.47 (s, 3H), 1.55 (s, 9H). 13C NMR (CDCl3)  methyl]-anthracen-9-ylmethyl}-methyl-carbamoyl)-
156.0, 132.6, 131.3, 130.2, 129.9, 126.1, 125.8, 125.4, 125.0, 80.1, ethyl]-phenyl}-propionyl)-methyl-amino]-methyl}-
57.6, 42.7, 31.8, 28.7. IR (cm1): 3413, 1681. HRMS (FAB) calculated anthracen-9-ylmethyl)-methyl-carbamic acid
for C22H25NO3 (M	) 351.1834, found 351.1835. Elemental analysis tert-butyl ester (6d)
calculated for C22H25NO3: C, 75.19; H, 7.17; N, 3.99. Found: C, 75.21; Yield 73%. 1H NMR (CDCl3)  8.48–8.45 (m, 4H), 8.38–8.35 (m, 4H),
7.57–7.54 (m, 8H), 7.18 (s, 4H), 5.71 (s, 4H), 5.53 (s, 4H), 3.06 (t, J H, 7.27; N, 3.97.
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8.7 Hz, 4H), 2.65 (t, J  8.7 Hz, 4H), 2.53 (s, 6H), 2.48 (s, 6H), 1.56 (s, 2H), 2.65 (s, 3H), 2.62 (s, 3H), 2.53 (s, 3H), 2.49 (s, 3H), 1.58 (s,
(s, 18H). IR (cm1): 1684, 1643. HRMS (FAB) calculated for C58H67N4O6 18H). IR (cm1): 1682, 1626. HRMS (FAB) calculated for C55H61N4O7
(M	 	 H) 915.5061 found 915.5070. (M	 	 H) 889.4462, found 889.4086. Elemental analysis calculated
[10-({[4-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]- for C52H60N4O7·H2O: C, 73.56; H, 6.85; N, 6.23. Found: C, 73.31; H,
anthracen-9-ylmethyl}-methyl-carbamoyl)-butyryl]- 7.50; N, 5.35.
methyl-amino}-methyl)-anthracen-9-ylmethyl]-methyl- [10-({[13-({10-[(Tert-Butoxycarbonyl-methyl-amino)-
carbamic acid tert-butyl ester (6e) methyl]-anthracen-9-ylmethyl}-methyl-carbamoyl)-
Yield 53%. 1H NMR (CDCl3)  8.48–8.45 (m, 4H), 8.39–8.35 (m, 4H), tridecanoyl]-methyl-amino}-methyl)-anthracen-9-ylmethyl]-
7.55–7.52 (m, 8H), 5.69 (s, 4H), 5.54 (s, 4H), 2.63 (s, 6H), 2.54 (t, J  methyl-carbamic acid tert-butyl ester (6m)
7.0 Hz, 4H), 2.48 (s, 6H), 2.20–2.10 (m, 2H), 1.57 (s, 18H). IR (cm1): Yield 52%. 1H NMR (CDCl3)  8.60–8.36 (m, 8H), 7.64–7.46 (m, 8H),
1685, 1639. HRMS (FAB) calculated for C51H61N4O6 (M	 	 H) 825.4591, 5.72 (s, 4H), 5.55 (s, 4H), 2.60 (s, 6H), 2.50 (s, 6H), 2.42–2.32 (m,
found 825.4627. Elemental analysis calculated for C51H60N4O6·1.5H2O: 4H), 1.92–1.20 (m, 20H), 1.56 (s, 18H). HRMS (FAB) calculated for
C, 71.82; H, 7.39; N, 6.57. Found: C, 71.93; H, 7.43; N, 6.27. C60H79N4O6 (M	 	 H) 951.6000, found 951.6009. Elemental analysis
[10-({[2-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]- calculated. for C60H78N4O6: C, 75.75; H, 8.26; N, 5.89. Found: C, 75.55;anthracen-9-ylmethyl}-methyl-carbamoyl)-benzoyl]- H, 8.37; N, 5.75.
methyl-amino}-methyl)-anthracen-9-ylmethyl]-methyl-
[10-({[2-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]-
carbamic acid tert-butyl ester (6f)
anthracen-9-ylmethyl}-methyl-carbamoyl)-biphenyl-2-
Yield 64%. 1H NMR (CDCl3)  8.58–8.51 (m, 8H), 7.67–7.60 (m, 8H), carbonyl]-methyl-amino}-methyl)-anthracen-9-ylmethyl]-7.29–7.26 (m, 2H), 7.08 (m, 2H), 5.94 (s, 4H), 5.58 (s, 4H), 2.67 (s,
methyl-carbamic acid tert-butyl ester (6n)6H), 2.53 (s, 6H), 1.57 (s, 18H). IR (cm1): 1680, 1633. HRMS (FAB)
Yield 59%. 1H NMR (CDCl3)  8.54–8.20 (m, 8H), 7.64–7.44 (m, 8H),calculated for C54H59N4O6 (M	 	 H) 859.4435, found 859.4449. Ele-
7.42–7.20 (m, 8H), 5.51 (s, 8H), 5.51 (s, 8H), 2.47 (s, 12H), 1.57 (s,mental analysis calculated for C54H58N4O6·1.5H2O: C, 73.13; H, 6.88;
18H). HRMS (FAB) calculated for C60H63N4O6 (M	 	 H) 935.4748,N, 6.32. Found: C, 73.02; H, 6.68; N, 6.21.
found 935.4770. Elemental analysis calculated. for C60H62N4O6·[10-({[5-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]-
0.5H2O: C, 76.32; H, 6.72; N, 5.93. Found: C, 76.57; H, 7.09; N, 5.65.anthracen-9-ylmethyl}-methyl-carbamoyl)-pent-3-
[10-({[4’-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]-enoyl]-methyl-amino}-methyl)-anthracen-9-ylmethyl]-
anthracen-9-ylmethyl}-methyl-carbamoyl)-biphenyl-4-methyl-carbamic acid tert-butyl ester (6g)
carbonyl]-methyl-amino}-methyl)-anthracen-9-ylmethyl]-Yield 31%. 1H NMR (CDCl3)  8.46–8.43 (m, 4H), 8.36–8.32 (m, 4H),
methyl-carbamic acid tert-butyl ester (6o)7.59–7.56 (m, 8H), 5.79 (s, 2H), 5.68 (s, 4H), 5.52 (s, 4H), 3.24 (s, 4H),
Yield 62%. 1H NMR (CDCl3)  8.40–8.20 (m, 8H), 7.80–7.40 (m, 16H),2.56 (s, 6H), 2.48 (s, 6H), 1.56 (s, 18H). IR (cm1): 1689, 1642. HRMS
5.90 (s, 4H), 5.57 (s, 4H), 2.60 (s, 6H), 2.52 (s, 6H), 1.58 (s, 18H).(FAB) calculated for C52H61N4O6 (M	 	 H) 837.4591, found 837.4592.
Elemental analysis calculated for C52H60N4O6·2 H2O: C, 71.55; H, 7.33; HRMS (FAB) calculated for C60H63N4O6 (M	 	 H) 935.4748, found
N, 6.42. Found: C, 71.70; H, 7.03; N, 6.31. 935.4775. Elemental analysis calculated. for C60H62N4O6·0.5H2O: C,
[10-({[3-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]- 76.32; H, 6.72; N, 5.93. Found: C, 76.29; H, 6.68; N, 5.94.
anthracen-9-ylmethyl}-methyl-carbamoyl)-propionyl]- [10-({[6-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]-
methyl-amino}-methyl)-anthracen-9-ylmethyl]-methyl- anthracen-9-ylmethyl}-methyl-carbamoyl)-hexanoyl]-
carbamic acid tert-butyl ester (6h) methyl-amino}-methyl)-anthracen-9-ylmethyl]-methyl-
Yield 78%. 1H NMR (CDCl3)  8.48–8.41 (m, 8H), 7.60–7.55 (m, 8H), carbamic acid tert-butyl ester (6p)
5.77 (s, 4H), 5.56 (s, 4H), 2.86 (s, 4H), 2.79 (s, 6H), 2.50 (s, 6H), 1.53 Yield 56%. 1H NMR (CDCl3)  8.52–8.36 (m, 8H), 7.64–7.54 (m, 8H),
(s, 18H). IR (cm1): 1685, 1643. HRMS (FAB) calculated for C50H59N4O6 5.71 (s, 4H), 5.54 (s, 4H), 2.60 (s, 6H), 2.49 (s, 6H), 2.41 (t, J  7.5
(M	 	 H) 811.4356, found 811.4412. Elemental analysis calculated Hz, 4H), 1.90–1.20 (m, 6H), 1.57 (s, 18H). IR (cm1): 1683, 1635. HRMS
for C50H58N4O6: C, 74.05; H, 7.21; N, 6.91. Found: C, 74.01; H, 7.34; (FAB) calculated for C53H65N4O6 (M	 	 H) 853.4904; found 853.4916.N, 6.63.
[10-({[4-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]-[10-({[7-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]-
anthracen-9-ylmethyl}-methyl-carbamoyl)-benzoyl]-anthracen-9-ylmethyl}-methyl-carbamoyl)-heptanoyl]-
methyl-amino}-methyl)-anthracen-9-ylmethyl]-methyl-methyl-amino}-methyl)-anthracen-9-ylmethyl]-methyl-
carbamic acid tert-butyl ester (6q)carbamic acid tert-butyl ester (6i)
Yield 57%. 1H NMR (CDCl3)  8.60–8.40 (m, 8H), 7.63–7.55 (m, 8H),Yield 75%. 1H NMR (CDCl3)  8.49–8.38 (m, 8H), 7.58–7.55 (m, 8H),
7.40 (s, 4H), 5.86 (s, 4H), 5.55 (s, 4H), 2.51 (s, 12H), 1.62 (s, 18H). IR5.71 (s, 4H), 5.54 (s, 4H), 2.60 (s, 6H), 2.50 (s, 6H), 2.39 (t, J  1.5
(cm1): 1684, 1635. HRMS (FAB) calculated for C54H59N4O6 (M	 	 H)Hz, 4H), 1.90–1.40 (m, 8H), 1.58 (s, 18H). IR (cm1): 1684, 1636. HRMS
859.4435; found 859.4451.(FAB) calculated for C54H69N4O6 (M	 	 H) 867.4982, found 867.5229.
{10-[({4-[4-({10-[(Tert-Butoxycarbonyl-methyl-amino)-[10-({[21-({10-[(Tert-Butoxycarbonyl-methyl-amino)-
methyl]-anthracen-9-ylmethyl}-methyl-carbamoyl)-methyl]-anthracen-9-ylmethyl}-methyl-carbamoyl)-
phenoxy]-benzoyl}-methyl-amino)-methyl]-anthracen-9-heneicosanoyl]-methyl-amino}-methyl)-anthracen-9-
ylmethyl]-methyl-carbamic acid tert-butyl ester (6j) ylmethyl}-methyl-carbamic acid tert-butyl ester (6r)
Yield 64%. 1H NMR (CDCl3)  8.49–8.38 (m, 8H), 7.59–7.56 (m, 8H), Yield 79%. 1H NMR (CDCl3)  8.60–8.40 (m, 8H), 7.70–7.50 (m, 8H),
5.72 (s, 4H), 5.55 (s, 4H), 2.60 (s, 6H), 2.50 (s, 6H), 2.40–2.34 (m, 4H), 7.49–7.39 (m, 4H), 7.09–6.99 (m, 4H), 5.84 (s, 4H), 5.55 (s, 4H), 2.58
1.90–1.20 (m, 54H). IR (cm1): 1692, 1643. HRMS (FAB) calculated (s, 6H), 2.40 (s, 6H), 1.57 (s, 18H). IR (cm1): 1682, 1632. HRMS (FAB)
for C68H95N4O6 (M	 	 H), 1063.7173, found 1063.5746. Elemental calculated for C60H63N4O7 (M	 	 H) 951.4697; found 951.4684.
analysis calculated for C54H58N4O6·0.5H2O: C, 72.15; H, 8.92; N, 5.22. [10-({[4-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]-
Found: C, 76.15; H, 8.92; N, 4.76. anthracen-9-ylmethyl}-methyl-carbamoyl)-
[10-({[3-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]- cyclohexanecarbonyl]-methyl-amino}-methyl)-anthracen-9-
anthracen-9-ylmethyl}-methyl-carbamoyl)-benzoyl]- ylmethyl]-methyl-carbamic acid tert-butyl ester (6s)
methyl-amino}-methyl)-anthracen-9-ylmethyl]-methyl- Yield 83%. 1H NMR (CDCl3)  8.60–8.40 (m, 4H), 8.38–7.22 (m, 4H),carbamic acid tert-butyl ester (6k)
7.70–7.50 (m, 8H), 5.72 (s, 4H), 5.55 (s, 4H), 2.66 (s, 6H), 2.45 (s, 6H),
Yield 74%. 1H NMR (CDCl3)  8.52–8.45 (m, 8H), 7.60–7.56 (m, 8H), 1.90–1.86 (m, 4H), 1.77–1.50 (m, 4H), 1.55 (s, 18H). IR (cm1): 1682,7.50–7.40 (m, 4H), 5.85 (s, 4H), 5.58 (s, 4H), 2.53 (s, 12H), 1.59 (s,
1634. HRMS (FAB) calculated for C54H63N4O6 (M	 	 H) 865.4904;18H). IR (cm1): 1688, 1632. HRMS (FAB) calculated for C54H59N4O6
found 865.4886.(M	 	 H) 859.4435, found 859.4832. Elemental analysis calculated
[10-({[4-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]-for C54H58N4O6·1.5H2O: C, 73.20; H, 6.88; N, 6.32. Found: C, 73.46;
anthracen-9-ylmethyl}-methyl-carbamoyl)-H, 6.93; N, 6.05.
cyclohexanecarbonyl]-methyl-amino}-methyl)-anthracen-9-{10-[({4-[({10-[(Isopropoxycarbonyl-methyl-amino)-methyl]-
ylmethyl]-methyl-carbamic acid tert-butyl ester (6t)anthracen-9-ylmethyl}-methyl-carbamoyl)-methoxy]-
Yield 83%. 1H NMR (CDCl3)  8.60–8.40 (m, 8H), 7.70–7.50 (m, 8H),benzoyl}-methyl-amino)-methyl]-anthracen-9-ylmethyl}-
5.77 (s, 4H), 5.56 (s, 4H), 2.70 (s, 6H), 2.55 (s, 6H), 2.56–2.22 (m, 4H),methyl-carbamic acid tert-butyl ester (6l)
1.48 (s, 18H), 1.40–1.20 (m, 4H). IR (cm1): 1686, 1637. HRMS (FAB)Yield 60%. 1H NMR (CDCl3)  8.50–8.31 (m, 8H), 7.62–7.43 (m, 10H),
6.99–6.96 (m, 2H), 5.86 (s, 2H), 5.72 (s, 2H), 5.58–5.54 (m, 4H), 4.79 calculated for C54H65N4O6 (M	 	 H) 865.4904; found 865.4886.
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[10-({[6-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]- 3.75 (s, 4H), 2.54 (s, 6H), 2.25 (s, 6H). IR (cm1): 1637. MS-ESI: 478.4
(M	 	 2H)/2. Elemental analysis calculated for C60H60B2N4O6·2.4H2O:anthracen-9-ylmethyl}-methyl-carbamoyl)-
C, 72.21; H, 6.49; N, 5.61. Found: C, 71.96; H, 6.19; N, 5.39.naphthalene-2-carbonyl]-methyl-amino}-methyl)-
Diboronic Acid 7canthracen-9-ylmethyl]-methyl-carbamic acid tert-butyl
Yield 38%. 1H NMR (CD3OD 	 CDCl3)  8.32–8.29 (m, 4H), 8.26–8.21ester (6u)
(m, 4H), 7.80–7.22 (m, 16H), 7.00 (s, 4H), 5.63 (s, 4H), 4.99 (s, 4H),Yield 67%. 1H NMR (CDCl3)  8.53–8.50 (m, 8H), 7.89–7.86 (m, 4H),
4.78 (s, 4H), 4.33 (s, 4H), 2.40 (s, 6H), 2.37 (s, 6H). IR (cm1): 1655.7.62–7.51 (m, 10H), 5.91 (s, 4H), 5.56 (s, 4H), 2.59 (s, 6H), 2.51 (s,
MS-ESI: 494.4 (M	 	 2H)/2.6H), 1.57 (s, 18H). IR (cm1): 1688, 1631. MS-FAB 909.8 (M	 	 H).
Diboronic Acid 7d[10-({[5-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]-
Yield 69%. 1H NMR (CD3OD 	 CDCl3)  8.35–8.32 (m, 4H), 8.25–8.22anthracen-9-ylmethyl}-methyl-carbamoyl)-thiophene-2-
(m, 4H), 7.67–7.65 (m, 2H), 7.55–7.52 (m, 8H), 7.35–7.25 (m, 6H), 7.11carbonyl]-methyl-amino}-methyl)-anthracen-9-ylmethyl]-
(s, 4H), 5.63 (s, 4H), 5.01 (s, 4H), 4.28 (s, 4H), 2.96 (t, J  7.2 Hz,methyl-carbamic acid tert-butyl ester (6v)
4H), 2.64 (t, J  7.2 Hz, 4H), 2.37 (s, 6H), 2.33 (s, 6H). IR (cm1):Yield 55%. 1H NMR (CDCl3)  8.52–8.49 (m, 4H), 8.39–8.37 (m, 4H),
1637. MS-ESI: 492.4 (M	 	 2H)/2.7.61–7.56 (m, 8H), 7.24 (s, 2H), 5.86 (s, 4H), 5.56 (s, 4H), 2.80 (s,
Diboronic Acid 7e6H), 2.51 (s, 6H), 1.56 (s, 18H). IR (cm1): 1686, 1612. HRMS (FAB)
Yield 58%. 1H NMR (CD3OD 	 CDCl3)  8.44–8.41 (m, 4H), 8.30–8.27calculated for C52H57N4O6S (M	 	 H) 865.3999, found 865.3973.
(m, 4H), 7.80–7.60 (m, 2H), 7.57–7.54 (m, 8H), 7.36–7.28 (m, 6H), 5.71[10-({[5-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]-
(s, 4H), 5.07 (s, 4H), 4.29 (s, 4H), 2.60 (s, 6H), 2.53 (t, J  7.1 Hz,anthracen-9-ylmethyl}-methyl-carbamoyl)-pyridine-3-
4H), 2.39 (s, 6H), 2.15–2.10 (m, 2H). IR (cm1): 1632. MS-ESI: 875.7carbonyl]-methyl-amino}-methyl)-anthracen-9-ylmethyl]-
(M	 H2O	H). Elemental analysis calculated for C55H58B2N4O6·H2O:methyl-carbamic acid tert-butyl ester (6w)
C, 72.53; H 6.59; N, 6.15. Found: C, 72.19; H, 6.16; N, 5.76.Yield 69%. 1H NMR (CDCl3)  8.64 (s, 2H), 8.55–8.52 (m, 4H), 8.43–8.41
Diboronic Acid 7f(m, 4H), 7.85 (s, 1H), 7.62–7.59 (m, 8H), 5.87 (s, 4H), 5.58 (s, 4H),
Yield 32%. 1H NMR (CD3OD 	 CDCl3)  8.62–8.60 (m, 4H), 8.34–8.312.58 (s, 6H), 2.52 (s, 6H), 1.58 (s, 18H). IR (cm1): 1682, 1632. HRMS
(m, 4H), 7.70–7.59 (m, 10H), 7.39–7.27 (m, 10H), 5.88 (s, 4H), 5.09 (s,(FAB) calculated for C53H58N5O6 (M	) 860.4387, found 860.4412. 4H), 4.36 (s, 4H), 2.61 (s, 6H), 2.44 (s, 6H). IR (cm1): 1633. MS-ESI:[10-({[15-({10-[(Tert-Butoxycarbonyl-methyl-amino)-
909.6 (M	  H2O 	 H). Elemental analysis calculated formethyl]-anthracen-9-ylmethyl}-methyl-carbamoyl)-
C58H56B2N4O6·2H2O: C, 72.36; H, 6.23; N, 5.82. Found: C, 72.26; H,pentadecanoyl]-methyl-amino}-methyl)-anthracen-9-
5.75; N, 5.48.ylmethyl]-methyl-carbamic acid tert-butyl ester (6x)
Diboronic Acid 7gYield 63%. 1H NMR (CDCl3)  8.52–8.49 (m, 4H), 8.43–8.40 (m, 4H), Yield 71%. 1H NMR (CD3OD 	 CDCl3)  8.31–8.28 (m, 4H), 8.18–8.157.61–7.58 (m, 8H), 5.74 (s, 4H), 5.57 (s, 4H), 2.62 (s, 6H), 2.52 (s, 6H),
(m, 4H), 7.56–7.50 (m, 8H), 7.40–7.30 (m, 8H), 5.65 (s, 2H), 5.57 (s,
2.40 (t, J  7.2 Hz, 4H), 1.75–1.58 (m, 22H), 1.36–1.29 (m, 20H). IR
4H), 4.90 (s, 4H), 4.26 (s, 4H), 3.18 (s, 4H), 2.33 (s, 6H), 2.16 (s, 6H).
(cm1): 1688, 1641. HRMS (FAB) calculated for C62H83N4O6 (M	 	 H) IR (cm1): 1642. MS-ESI: 887.6 (M	  H2O 	 H). Elemental analysis979.6313, found 979.6343.
calculated for C56H58B2N4O6: C, 74.34; H, 6.46; N, 6.19. Found: C,[10-({[5-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]-
74.38; H, 6.73; N, 6.21.
anthracen-9-ylmethyl}-methyl-carbamol)-pentanoyl]- Diboronic Acid 7h
methyl-amino}-methyl)-anthracen-9-ylmethyl]-methyl- Yield 50%. 1H NMR (CD3OD 	 CDCl3)  8.49–8.46 (m, 4H), 8.24–8.22carbamic acid tert-butyl ester (6y) (m, 4H), 7.80–7.60 (m, 2H), 7.57–7.54 (m, 8H), 7.36–7.28 (m, 6H), 5.70
Yield 50%. 1H NMR (CDCl3)  8.50–8.30 (m, 8H), 7.60–7.40 (m, 8H), (s, 4H), 4.96 (s, 4H), 4.33 (s, 4H), 2.78(s, 4H), 2.69 (s, 6H), 2.39 (s,
5.72 (s, 4H), 5.51 (s, 4H), 2.55 (s, 6H), 2.50 (s, 6H), 2.50–2.44 (m, 4H), 6H). IR (cm1): 1643, 1632. MS-ESI: 861.5 (M	  H2O 	 H).1.90–1.60 (m, 4H), 1.57 (s, 18H). Diboronic Acid 7i
[10-({[4-({10-[(Tert-Butoxycarbonyl-methyl-amino)-methyl]- Yield 49%. 1H NMR (CD3OD 	 CDCl3)  8.50–8.25 (m, 8H), 7.71–7.57
anthracen-9-ylmethyl}-methyl-carbamoyl)- (m, 10H), 7.35–7.28 (m, 6H), 5.73 (s, 4H), 5.16 (s, 4H), 4.30 (s, 4H),
naphthalene-1-carbonyl]-methyl-amino}-methyl)- 2.59 (s, 6H), 2.47 (s, 6H), 2.39 (t, J  7.3 Hz, 4H), 1.80–1.60 (m, 4H),
anthracen-9-ylmethyl]-methyl-carbamic 1.50–1.35 (m, 4H). IR (cm1): 1632. MS-ESI: 917.5 (M	  H2O 	 H).
acid tert-butyl ester (6z) Diboronic Acid 7j
Yield 33%. 1H NMR (CDCl3) d 8.80-8.40 (m, 8H), 8.00-7.40 (m, 14H), Yield 30%. 1H NMR (CD3OD 	 CDCl3)  8.45–8.43(m, 4H), 8.28–8.26
6.10 (s, 4H), 5.65 (s, 4H), 2.60 (s, 6H), 2.40 (s, 6H), 1.60 (s, 18H). (m, 4H), 7.67–7.59 (m, 10H), 7.38–7.36 (m, 6H), 5.70 (s, 4H), 5.11 (s,
HRMS (FAB) calculated for C58H61N4O6 (M	 	 H) 909.4591, found 4H), 4.39 (s, 4H), 2.59 (s, 6H), 2.50–2.38 (m, 10H), 1.66–1.61 (m, 4H),
909.4583. Elemental analysis calculated. for C58H60N4O6: C, 76.63; H, 1.40–1.18 (m, 32H). IR (cm1): 1649, 1632. MS-ESI: 1113.8 (M	 
6.65; N, 6.16. Found: C, 76.36; H, 6.72; N, 6.04. H2O 	 H).
General Procedures for Preparation of the Symmetrical Diboronic Acid 7k
Diboronic Acids (7) Yield 50%. 1H NMR (CD3OD 	 CDCl3)  8.50–8.34 (m, 8H), 7.71–7.61
The Boc-protected diamine compound 6 (0.073 mmol) was dis- (m, 12H), 7.45–7.34 (m, 8H), 5.86 (s, 4H), 5.06 (s, 4H), 4.24 (s, 4H),
solved in dry CH2Cl2 (8mL), then trifluoroacetic acid (3 mL) was 2.57 (s, 6H), 2.42 (s, 6H). IR (cm1): 1631, 1620. MS-ESI: 909.5 (M	 
added. After the mixture was stirred at room temperature for 10 H2O 	 H).
min, the solvent was removed. The residue was dried in vacuo for Diboronic Acid 7l
3 hr and dissolved in dry acetonitrile (30 mL); compound 8 (85 Yield 40%. 1H NMR (CD3OD 	 CDCl3)  8.46–8.30 (m, 8H), 8.29–7.56
mg, 0.30 mmol), potassium carbonate (100 mg, 0.73 mmol) and (m, 10H), 7.28–7.26 (m, 8H), 7.10–6.90 (m, 2H), 5.89 (s, 2H), 5.76 (s,
potassium iodide (2 mg) were then added. The reaction mixture was 2H), 5.16 (s, 2H), 5.12 (s, 2H), 4.90 (s, 2H), 4.38 (s, 2H), 4.35 (s, 2H),
stirred at room temperature for 12 hr. The insoluble materials were 2.68 (s, 3H), 2.63 (s, 3H), 2.46 (s, 3H), 2.42 (s, 3H). IR (cm1): 1632,
filtered off, and the filtrate was evaporated in vacuo. The resulting 1608. MS-ESI: 939.5 (M	  H2O 	 H).
residue was dissolved in CH2Cl2 and 10% aqueous solution of so- Diboronic Acid 7m
dium bicarbonate (20 mL) and the mixture was stirred at room tem- Yield 42%. 1H NMR (CD3OD)  8.50–8.38 (m, 4H), 8.32–8.24 (m, 4H),
perature for 1 hr. The organic phase was separated and washed 7.74–7.64 (m, 2H), 7.62–7.54 (m, 6H), 7.40–7.20 (m, 8H), 5.68 (s, 4H),
with water (2  30 mL) and dried over MgSO4. After removal of the 5.06 (s, 4H), 4.37 (s, 4H), 2.58 (s, 6H), 2.50–2.34 (m, 4H), 2.46 (s, 6H),
solvent, the crystalline was precipitated from CH2Cl2/Et2O. 1.70–1.48 (m, 4H), 1.40–1.20 (m, 16H). ESI-MS: 1001.7 (M	 H2O	H).
Diboronic Acid 7a Diboronic Acid 7n
Yield 49%. 1H NMR (CD3OD)  8.46–8.43 (m, 4H), 8.29–8.24 (m, 4H), Yield 76%. 1H NMR (CD3OD 	 CDCl3)  8.45–7.10 (m, 32H), 5.80 (s,
7.70–7.67 (m, 2H), 7.59–7.55 (m, 8H), 7.36–7.26 (m, 6H), 5.68 (s, 4H), 4H), 4.70 (s, 4H), 4.35 (s, 4H), 2.25 (s, 12H). ESI-MS: 985.6 (M	 
5.06 (s, 4H), 4.36 (s, 4H), 2.58 (s, 6H), 2.43–2.38 (m, 4H), 1.64–1.54 (m, H2O 	 H).
4H), 1.36–1.28 (m, 12H). IR (cm1): 1637. MS-ESI: 496.4 (M	 	 2H)/2. Diboronic Acid 7o
Diboronic Acid 7b Yield 89%. 1H NMR (CD3OD 	 CDCl3)  8.60–8.50 (m, 4H), 8.40–8.24
Yield 81%. 1H NMR (CD3OD 	 CDCl3)  8.40–8.36 (m, 4H), 8.25–8.22 (m, 4H), 7.90–7.20 (m, 24H), 5.90 (s, 4H), 4.94 (s, 4H), 4.20 (s, 4H),
2.62 (s, 6H), 2.40 (s, 6H). ESI-MS: 985.6 (M	  H2O 	 H).(m, 4H), 7.82–7.18 (m, 20H), 5.69 (s, 4H), 4.89 (s, 4H), 4.08 (s, 4H),
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Diboronic Acid 7p clone A70-C/C8, NeoMarkers) at a dilution of 1:20, anti-sialyl Lewis
X (CSLEX-1 and KM93) at 10g/ml, and anti-sialyl Lewis a (CSLEA-1)Yield 78%. 1H NMR (CD3OD 	 CDCl3)  8.50–8.36 (m, 4H), 8.32–8.16
(m, 4H), 7.74–7.44 (m, 10H), 7.42–7.20 (m, 6H), 5.64 (s, 4H), 4.99 (s, at 1:500. Cells were then stained with fluorescein isothiocyanate-
conjugated goat anti-mouse IgM or anti-mouse IgG. FITC-conju-4H), 4.35 (s, 4H), 2.42–2.30 (m, 4H), 2.41 (s, 6H), 2.37 (s, 6H), 1.70–1.54
(m, 4H), 1.46–1.32 (m, 2H). IR (cm1): 1639. MS-ESI: 949.5 (M	 	 gated murine IgG1/IgG2 and anti-CD18 antibodies (negative con-
trols throughout) were used according to the manufacturer’s instruc-2MeOH  2H2O 	 H).
Diboronic Acid 7q tions. Cells were analyzed on a Becton-Dickinson FACScan as
previously described (13, 14).Yield 70%. 1H NMR (CD3OD)  8.60–8.40 (m, 4H), 8.32–8.20 (m, 4H),
7.72–7.52 (m, 12H), 7.50–7.20 (m, 8H), 5.81 (s, 4H), 5.06 (s, 4H), 4.34 Fluorescent Labeling Studies
Six-well plates were seeded with 1 106 cells per well and incubated(s, 4H), 2.47 (s, 6H), 2.39 (s, 6H). IR (cm1): 1626. MS-ESI: 969.5
(M	 	 3MeOH  3H2O 	 H). Elemental analysis calculated for at 37
C and 5% CO2 for 48 hr. The media was removed and cells
were washed twice with 1 PBS. The cells were fixed with 1.5 mlC58H56B2N4O6·2H2O: C, 72.28; H, 6.07; N, 5.82. Found: C, 72.27; H,
6.05; N, 5.87. of 1:1 methanol/PBS and incubated 20 min at 4
C. After incubation,
the methanol/PBS solution was removed and cells were washedDiboronic Acid 7r
Yield 65%. 1H NMR (CD3OD)  8.60–8.42 (m, 4H), 8.40–8.30 (m, 4H), twice with PBS.
Diboronic acid compounds were resuspended in 1:1 methanol/7.80–7.52 (m, 10H), 7.50–7.20 (m, 10H), 7.15–7.00 (m, 4H), 5.81 (s,
4H), 5.04 (s, 4H), 4.35 (s, 4H), 2.54 (s, 6H), 2.40 (s, 6H). IR (cm1): PBS and added to wells at 0.5–10 M concentrations. One well was
incubated only in methanol/PBS without compound as a negative1616. MS-ESI: 1029.5 (M	 	 2MeOH–3H2O 	 H).
Diboronic Acid 7s control. The plates were then incubated in darkness at 4
C for 45
min. Plates were examined with phase contrast microscopy followedYield 58%. 1H NMR (CD3OD)  8.55–8.50 (m, 4H), 8.40–8.25 (m, 4H),
7.72–7.52 (m, 8H), 7.44–7.20 (m, 8H), 5.77 (s, 4H), 5.16 (s, 4H), 4.40 by fluorescent microscopy (blue cube wavelengths 370 nm excita-
tion, 426 nm emission; 20X lens). Plates were photographed using(s, 4H), 2.86–2.78 (m, 2H), 2.64 (s, 6H), 2.47 (s, 6H), 2.20–2.08 (m,
2H), 1.70–1.56 (m, 2H). IR (cm1): 1634. MS-ESI: 961.5 (M	 	 a Nikon DXM1200 digital camera and images captured with the
Nikon ACT-1 program (v 2.10). The phase contrast and fluorescent2MeOH  2H2O 	 H).
Diboronic Acid 7t images were then overlaid, organized and labeled using Adobe Pho-
toshop 6.0. The images were quantified with NIH ImageJ 1.28. TheYield 70%. 1H NMR (CD3OD)  8.50–8.40 (m, 4H), 8.38–8.24 (m, 4H),
7.76–7.52 (m, 10H), 7.40–7.24 (m, 6H), 5.70 (s, 4H), 5.10 (s, 4H), 4.40 units (mean gray value) were subtracted from background, where
there are no cells. The fluorescent signal was stable for at least 96(s, 4H), 2.80–2.62 (m, 2H), 2.66 (s, 6H), 2.44 (s, 6H), 1.90–1.74 (m,
2H), 1.70–1.60 (m, 2H). IR (cm1): 1634. MS-ESI: 960.4 (M	 	 hr when cells were maintained in darkness.
Neuraminidase and Fucosidase Studies2MeOH  2H2O). Elemental analysis calculated for C58H62B2N4O6·
3H2O: C, 70.59; H, 6.95; N, 5.82. Found C, 70.56; H, 6.35; N, 5.81. HEPG2 cells (sLex-expressing) were treated with neuraminidases
specific for  (2,3) sialic acid linkages (MDL number MFCD01092203,Diboronic Acid 7u
Yield 31%. 1H NMR (CD3OD 	 CDCl3)  8.68–8.50 (m, 4H), 8.33–8.31 SIGMA #N7271) and  (2,3)/ (2,6) sialic acid residues (MDL number
MFCD01092201, SIGMA #N5521) according to modifications of(m, 4H), 7.92–7.90 (m, 4H), 7.65–7.62 (m, 12H), 7.34–7.20 (m, 6H),
5.93 (s, 4H), 5.10 (s, 4H), 4.35 (s, 4H), 2.59 (s, 6H), 2.43 (s, 6H). IR manufacturer’s protocols. Incubations were performed in 20 mM
Tris-HCL (pH 7.5) 25 mM NaCl (5 reaction buffer is 250 mM sodium(cm1): 1613. MS-ESI: 959.4 (M	  H2O 	 H).
Diboronic Acid 7v phosphate [pH 6.0]) at 37
C for four hours. Control HEPG2 were
treated with buffer alone at the same conditions. Incubation of cellsYield 49%. 1H NMR (CD3OD 	 CDCl3)  8.42–8.40 (m, 4H), 8.29–8.26
(m, 4H), 7.69 (m, 2H), 7.60–7.55 (m, 8H), 7.37–7.25 (m, 8H), 5.82 (s, with fucosidase recognizing  (1,3)- and (1,4) –linked fucose (MDL
number MFCD00130491, SIGMA #F3023) were performed using the4H), 5.02 (s, 4H), 4.31 (s, 4H), 2.76 (s, 6H), 2.39 (s, 6H). IR (cm1):
1614. MS-ESI: 915.4 (M	  H2O 	 H). same buffers and conditions except the phosphate buffer is at pH
5.0. Incubation with both  (1,3/1,4)fucosidase (F3023) and Diboronic Acid 7w
Yield 65%. 1H NMR (CD3OD 	 CDCl3)  8.53–8.49 (m, 4H), 8.33–8.31 (2,3)neuraminidase (N7271) were performed with the same buffers
and conditions except the pH was 5.5. The cells were then stained(m, 4H), 7.68–7.60 (m, 10H), 7.37–7.22 (m, 9H), 5.84 (s, 4H), 5.07 (s,
4H), 4.33 (s, 4H), 2.56 (s, 6H), 2.41 (s, 6H). IR (cm1): 1631. MS-ESI: with 7q and controls, examined under fluorescent microscopy, and
photographed as above.910.4 (M	  H2O 	 H).
Diboronic Acid 7x
Yield 45%. 1H NMR (CD3OD 	 CDCl3)  8.44–8.40 (m, 4H), 8.32–8.22
Acknowledgments(m, 4H), 7.78–7.64 (m, 2H), 7.58–7.56 (m, 8H), 7.37–7.28 (m, 6H), 5.69
(s, 4H), 5.08 (s, 4H), 4.31 (s, 4H), 2.60 (s, 6H), 2.44–2.37 (m, 10H),
We gratefully acknowledge the financial support from the National1.80–1.60 (m, 4H), 1.35–1.27 (m, 20H). IR (cm1): 1637. MS-ESI:
Institutes of Health (NO1-CO-27184, CA88343, and DK55062) and1029.6 (M	  H2O 	 H).
North Carolina Biotechnology Center (2001ARG0016). The authorsDiboronic Acid 7y
wish to thank Bihui Zeng for expert assistance with cell labelingYield 91%. 1H NMR (CD3OD 	 CDCl3)  8.40–7.40 (m, 24H), 5.63 (s,
experiments.4H), 4.70 (s, 4H), 4.10 (s, 4H), 2.56 (s, 6H), 2.47 (t, J  7.0 Hz, 4H),
2.30 (s, 6H), 1.99–1.60 (m, 4H). ESI-MS: 889.6 (M	  H2O 	 H).
Elemental analysis calculated. for C56H60B2N4O6: C, 74.18; H, 6.67; N, References
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